MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

NeoGenomics Keeps Liquid Biopsy Consolidation Flowing with New M&A

hafakot -stock.adobe.com IMG_May72021at33357PM.jpg
NeoGenomics is set to acquire Inivata, a liquid biopsy specialist for $390 million.

Consolidation in the liquid biopsy market is continuing with NeoGenomics plan to acquire Inviata for about $390 million.

The acquisition follows a $25 million minority equity investment by Cambridge, U.K.-based NeoGenomics in Inivata in May 2020. It was at this time NeoGenomics was granted a fixed price option to purchase the remainder of Research Triangle Park, N.C.-based Inivata for $390 million.

Inivata, with its leading liquid biopsy technology platform, will remain a separate business division alongside NeoGenomics’ growing clinical, pharma and informatics divisions. Current Inivata CEO Clive Morris will become the President of Inivata and will report to Mark Mallon, CEO of NeoGenomics.

“Joining the NeoGenomics Group provides Inivata with an excellent foundation to support our growth ambitions,” Morris said in a release. “Our two organizations have highly complementary capabilities, and we are excited to combine with NeoGenomics following a successful year of working together. By leveraging our combined resources, we expect to accelerate the development of our promising RaDaR minimal residual disease assay and bolster commercialization efforts with biopharma before driving a successful launch into the clinical setting.”

There have been some high-profile mergers and acquisitions in the liquid biopsy space lately, which includes Thrive Earlier Detection Group being acquired by Exact Sciences for $2.15 billion.

Illumina is in the process of acquiring Grail for $8 billion – but the deal stalled after it came under fire by the Federal Trade Commission and European Commission Directorate General.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Find IVD Suppliers

Find suppliers of biochemicals, reagents, filters, membranes, assay system components, and contract manufacturing to the IVD sector on Qmed, the world's only director of pre-qualified suppliers to the medical device and diagnostics industry.